Witnessing the stock’s movement on the chart, on Wednesday Grifols SA ADR (NASDAQ: GRFS) had a quiet start as it plunged -1.39% to $6.39, before settling in for the price of $6.48 at the close. Taking a more long-term approach, GRFS posted a 52-week range of $5.30-$12.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 6.28%. Meanwhile, its Annual Earning per share during the time was -37.97%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 142.46%. This publicly-traded company’s shares outstanding now amounts to $256.91 million, simultaneously with a float of $256.76 million. The organization now has a market capitalization sitting at $1.64 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.05, while the 200-day Moving Average is $8.77.
Grifols SA ADR (GRFS) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – General industry. Grifols SA ADR’s current insider ownership accounts for 0.06%, in contrast to 48.41% institutional ownership.
Grifols SA ADR (GRFS) Earnings and Revenue Records
As on 12/31/2023, Multinational firm has announced its last quarter scores, in which it reported 0.04 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.22) by -0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.23 per share during the current fiscal year.
Grifols SA ADR’s EPS increase for this current 12-month fiscal period is 142.46% and is forecasted to reach 1.20 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.40% through the next 5 years, which can be compared against the -37.97% growth it accomplished over the previous five years trading on the market.
Grifols SA ADR (NASDAQ: GRFS) Trading Performance Indicators
Let’s observe the current performance indicators for Grifols SA ADR (GRFS). It’s Quick Ratio in the last reported quarter now stands at 1.29. The Stock has managed to achieve an average true range (ATR) of 0.32. Alongside those numbers, its PE Ratio stands at $25.48, and its Beta score is 0.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.23.
In the same vein, GRFS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.25, and analysts are predicting that it will be 1.20 at the market close of one year from today.
Technical Analysis of Grifols SA ADR (GRFS)
Going through the that latest performance of [Grifols SA ADR, GRFS]. Its last 5-days volume of 1.46 million was inferior to the volume of 2.92 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 23.07% While, its Average True Range was 0.28.
Raw Stochastic average of Grifols SA ADR (GRFS) in the period of the previous 100 days is set at 15.91%, which indicates a major rise in contrast to 12.73% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.08% that was lower than 89.54% volatility it exhibited in the past 100-days period.
